68Ga-RM2 Compared to 68Ga-PSMA-617 PET/CT for Intermediate Risk Prostate Cancer Imaging
Status:
Recruiting
Trial end date:
2020-12-17
Target enrollment:
Participant gender:
Summary
Patients with primary intermediate risk prostate cancer for whom radical prostatectomy is
indicated, will be invited to participate to the present study.
Positron Emission Tomography coupled with scanner (PET-CT) using a radiotracer : 68Ga-RM2 and
Positron Emission Tomography coupled with scanner (PET-CT) using another radiotracer :
68Ga-PSMA-617, will be scheduled.